Filter
2895
Filtered Results: 2895
Text search:
cohort
Featured
Recommendations
269
New Publications
592
Language
Document type
No document type
1548
Studies & Reports
534
Guidelines
494
Manuals
98
Strategic & Response Plan
78
Fact sheets
68
Situation Updates
28
Training Material
25
Infographics
9
Resource Platforms
5
Online Courses
5
Brochures
3
Countries / Regions
Global
97
India
91
Western and Central Europe
85
Kenya
81
South Africa
80
Latin America and the Carribbean
64
Russia
51
Ethiopia
47
Africa
47
Eastern Europe
46
Rwanda
44
Malawi
43
Uganda
37
Brazil
35
Ukraine
35
Nigeria
33
Nepal
33
Myanmar / Burma
32
Liberia
29
Bangladesh
29
Sierra Leone
28
Senegal
26
Ghana
25
Zambia
25
Colombia
25
Germany
24
Congo, Democratic Republic of
23
Asia
22
Argentina
21
Philippines
20
Tanzania
20
Middle East and North Africa
19
Paraguay
19
Lesotho
18
Zimbabwe
17
Mozambique
16
West and Central Africa
16
Eastern Europe and Central Asia
16
Syria
15
Ecuador
15
Chile
15
East and Southern Africa
15
South–East Asia Region
15
Indonesia
14
Namibia
14
Burkina Faso
13
Cameroon
13
Benin
13
Peru
13
Pakistan
12
Venezuela
12
Haiti
10
Cambodia
10
Botswana
9
Tajikistan
9
Guinea
8
Central African Republic
7
Bolivia
7
Western Pacific Region
7
Eswatini/ Swaziland
6
El Salvador
6
Yemen
6
Georgia
6
North America
6
Spain
6
Mali
5
USA
5
China
5
Angola
5
France
5
Guinea-Bissau
4
Côte d’Ivoire / Ivory Coast
4
Jordan
4
Turkey
4
Thailand
4
Madagascar
4
Southern Africa
4
Niger
3
Afghanistan
3
Egypt
3
Sudan
3
Dominican Republic
3
North Macedonia
3
Guatemala
3
Mexico
3
Sri Lanka
3
Albania
3
Armenia
3
Moldova
3
Kazakhstan
3
Vietnam
3
Iraq
2
Lebanon
2
Burundi
2
Honduras
2
Congo-Brazzaville
2
Timor Leste/ East Timor
2
Estonia
2
Kyrgyzstan
2
United Kingdom
2
Portugal
2
Belarus
2
Togo
1
South Sudan
1
Chad
1
Gambia
1
Ireland
1
Singapore
1
Serbia
1
Cuba
1
Nicaragua
1
Bhutan
1
Palestine
1
Italy
1
Canada
1
Romania
1
Uzbekistan
1
Uruguay
1
Belgium
1
Mauritius
1
Azerbaijan
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1023
Clinical Guidelines
303
Public Health
155
Women & Child Health
129
Key Resources
50
Capacity Building
24
Pharmacy & Technologies
11
Toolboxes
COVID-19
428
TB
396
HIV
362
Mental Health
258
NCDs
99
Rapid Response
71
Caregiver
65
NTDs
63
Disability
57
Planetary Health
53
Ebola
49
AMR
46
Global Health Education
33
Refugee
27
Pharmacy
27
Polio
25
Zika
22
Conflict
17
Cholera
13
Health Financing Toolbox
11
Natural Hazards
6
Specific Hazards
5
В целом считается, что люди, страдающие астмой (ЛСА), подвергаются повышенному риску при респираторных
инфекциях, что ежегодно подтверждается во время в...
People with asthma (PWA) generally are considered at higher risk from respiratory infections, as is seen annually with influenza. At the outset of the COVID-19 pandemic, PWA were widely assumed to be at increased risk from COVID-19. However, as data emerged throughout 2020, the association between a...
Note d’information scientifique, 17 juin 2021
Despite some improvements, current levels of air pollution still pose a considerable risk to the environment and to human health in the WHO European Region. One issue of concern is that monitoring of particulate matter is very limited in the countries of eastern Europe, the Caucasus and central Asia...
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch...
29 September 2021
Defeating meningitis by 2030: a global road map
Defeating meningitis by 2030: a roadmap
Les infections au SRAS-CoV-2 chez les enfants et les adolescents provoquent une maladie moins grave et moins de décès que chez les adultes. Bien qu'une évolution moins grave de l'infection soit un résultat positif, on s'inquiète du fait que des symptômes légers aient pu conduire à moins de t...
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch...
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch...
Vaccination programmes against COVID-19 and seasonal influenza are currently being implemented in parallel in many countries. Administration of both vaccines during the same visit has potential advantages. This document presents the evidence related to coadministration of Covid-19 and influenza vacc...
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021 (Arabic Version)
recommended
WHO has developed a clinical case definition of post COVID-19 condition by Delphi methodology that includes 12 domains, available for use in all settings. This first version was developed by patients, researchers and others, representing all WHO regions, with the understanding that the definition ma...
World Journal of Pharmaceutical and Medical Research vol. 5 (2019) 3, 129-132
This e-course will guide you through the essentials of latest existing WHO guidelines and policy recommendations on drug-resistant TB. You will also learn more about the rationale behind the WHO recommendations for the management of DR-TB, implementation considerations for different regimens for eli...
The Lancet March 17, 2022DOI:https://doi.org/10.1016/S0140-6736(22)00525-6
Cardiovascular disease, diabetes, chronic obstructive pulmonary disease, cancers, and other non-communicable diseases are among the leading causes of morbidity and mortality in low-income, middle-income, and high-income countries, and The Lancet Taskforce recently made the case for investing in non-...
